Segmentation by type isolates four core filter technologies that collectively underpin the market’s structural composition. Mechanical filters—including HEPA and ULPA media—dominate with an estimated 40 % share, favored for their high particulate removal efficiency and compliance with stringent medical standards. Electrostatic filters, representing roughly 25 % of sales, leverage charge‑based capture mechanisms that enable lower pressure drops, making them attractive for long‑duration industrial ventilation. Chemical/adsorptive filters, accounting for about 20 %, incorporate activated carbon or zeolite layers to remove gaseous contaminants, a capability increasingly required in pharmaceutical and semiconductor facilities. Finally, antimicrobial‑treated filters, comprising the remaining 15 %, embed biocidal agents to inhibit microbial growth, a feature gaining relevance in hospital settings to reduce infection risk. The relative contribution of each type reflects functional demands, regulatory pressures, and cost considerations, providing a granular view of the market taxonomy within Respiratory Filters.